Journal article
Influenza Vaccination and Vitamin K Antagonist Treatment: A Placebo-Controlled, Randomized, Double-blind Crossover Study
Abstract
BACKGROUND: Among millions of persons vaccinated against influenza virus each year, many are older patients treated with several drugs, including vitamin K antagonists (VKAs), among which warfarin is the most commonly used. Due to high interpatient and intrapatient variability, the therapeutic dose of VKA has to be individualized by monitoring of international normalized ratio (INR) values. The objectives of this study were to evaluate …
Authors
Iorio A; Basileo M; Marcucci M; Guercini F; Camilloni B; Paccamiccio E; Vecchioli M; Iorio AM
Journal
JAMA Internal Medicine, Vol. 170, No. 7, pp. 609–616
Publisher
American Medical Association (AMA)
Publication Date
April 12, 2010
DOI
10.1001/archinternmed.2010.49
ISSN
2168-6106